Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Nov. 30, 2015	Nov. 30, 2014	Nov. 30, 2015	Nov. 30, 2014
Revenue
Revenue
Total revenue
OPERATING EXPENSES
General & administrative	$ 656,929	$ 1,062,221	$ 2,681,857	$ 2,853,569
Research & development	405,911	287,561	943,205	1,031,517
Total Operating Expenses	1,062,840	1,349,782	3,625,062	3,885,086
OTHER EXPENSES (INCOME)
Interest expense	123,918	303	169,279	679,432
Other income, net	$ 7	$ 23,873	$ (140,129)	20,714
Beneficial conversion feature				2,324,758
Loss on securities held for sale		$ 33,707		$ 33,707
Change in fair value of warrant liability	$ 49,507		$ (123,393)
Change in fair value of put embedded in note payable			3,134
Settlement expense			39,097
Total Other Expenses (Income)	$ 173,432	$ 57,883	(52,012)	$ 3,058,611
NET LOSS	(1,236,272)	(1,407,665)	(3,573,050)	(6,943,697)
Net loss	(1,236,272)	$ (1,407,665)	(3,573,050)	$ (6,943,697)
Deemed dividend on Series B Preferred Stock issuance			(1,067,491)
Accrued dividends on Series B Preferred Stock	(70,590)		(195,057)
Loss attributable to common shareholders	$ (1,306,862)	$ (1,407,665)	$ (4,835,598)	$ (6,943,697)
Net loss per share, basic and diluted	$ (0.72)	$ (0.79)	$ (2.67)	$ (4.30)
Weighted average of shares outstanding	1,821,182	1,779,662	1,812,825	1,615,339